Skip to main content
. 2016 Mar 10;2016(3):MR000043. doi: 10.1002/14651858.MR000043.pub2

Francis 2002.

Methods RCT comparing ximelagatran versus warfarin for the prevention of thromboembolism after total knee arthroplasty.
Data 680 patients were randomised (348/332, respectively in each treatment group).
Comparisons Onsite assessment (local investigator blinded) versus assessment by an AC blinded to allocated treatment.
Outcomes The outcome selected was total thromboembolism. The study's primary outcome was the incidence of deep venous thrombosis (proximal or distal) or pulmonary embolism.
Notes  
Risk of bias
Item Authors' judgement Description
Method for selecting cases to adjudicate? No All suspect events adjudicated were identified by onsite assessor who was blinded to allocated treatment.